Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PFIZER

Pfizer, Inc. is the world’s largest pharmaceutical company in the world, by sales. The New York-based company produces the No. 1-selling drug, along with other widely used prescription drugs as Lipitor, Lyriuca, Diflucan, Celebrex and Viagra. This topic covers the latest news on Pfizer.

Pfizer is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 1,236 news and 381 blog items. Read updated news, blogs, and resources about Pfizer. Find user-submitted articles and reactions on Pfizer from like-minded professionals.

News

Please add new articles to this topic

Icon pharma firm to partner with Pfizermore

Pharmaceutical company Icon has announced a partnership with Pfizer, which will see it serve as one of two providers of...

Claris gets Russian nod for anti-infective drugsmore

to close at Rs 161.40. The Ahmedabad-based company entered into licencing deal for its generic injectables with Pfizer...

Missing reports show Chantix suicides in smokersmore

problems tied to the popular stop-smoking drug Chantix were left out of a crucial government safety review because...

Study Questions Treatment Used in Heart Diseasemore

levels, their patients would benefit. So far, that assumption is not panning out. Nobody knows why. In 2006, Pfizer...

ICON Selected By Pfizer As A Global Strategic Partner For Clinical Res...more

of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced...

Republicans Ponder Plan for 20% Small-Business Tax Deductionmore

one-time holiday on repatriated profits. They are supported by companies such as Cisco Systems Inc., Microsoft Corp.

Reportlinker Adds Innovations in Protein Kinase Therapies - Significan...more

Protein Kinases Pipeline Overview 49 5.2 Protein Kinase Pipeline Profile of Top 10 Companies 50 5.3 Pfizer 52 5.3.

Big cap stocks are getting a bum rapmore

truly mad. That observation led to this wonky rant: "[Microsoft] now trades at a similar price-to-earnings ratio...

InSite Vision Announces Joint Patent Infringement Lawsuit With Merck A...more

it will join Merck (NYSE:MRK), known as MSD outside the United States (U.S.) and Canada, and Pfizer Inc.

Republicans Edge Away from 20 Percent Small Business Deductionmore

one-time holiday on repatriated profits. They are supported by companies such as Cisco Systems Inc., Microsoft Corp.

Why investors think big tech stocks are lamemore

truly mad. That observation led to this wonky rant: "[Microsoft] now trades at a similar price-to-earnings ratio...

Abbott Cholesterol Combination Fails to Protect Heart in Studymore

government study failed to show heart benefits. Questions about the benefits of raising good cholesterol have swirled...

Drug companies in America: The costly war on cancermore

Extract not available.

Pfizer must walk the line on arthritis pill pricemore

pills By Ben Hirschler LONDON, May 26 (Reuters) - Price may be the biggest factor in deciding whether Pfizer Inc (PFE.

Pfizer Announces New Results From Multiple Studies Of ENBRELmore

Extract not available.

Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership...more

global biopharmaceutical services provider, today announced that it has been selected as one of two strategic partners...

Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Comingmore

treating advanced melanoma, and neither had been proven to prolong life. Melanoma drugs from companies including New...

Biotech Calendar: 2011 FDA Drug Approvalsmore

for kidney transplant rejection FDA approval decision date: June 15, 2011 FDA initially rejected belatacept in May 2010.

Arthritis Drug���s $1.4 Billion Promise for 4SC Hinges on Studymore

but less than 10.��� Vidofludimus would offer an oral, lower-priced alternative to injected therapies such as Enbrel...

Pfizer Announces Detailed Results Of ORAL Sync Showing Investigational...more

Extract not available.

Satisfying Clinical Trial Straightens Up Sharesmore

the help it can get on the marketing front. After its approval, avanafil will have to compete against Pfizer's (NYSE:...

Does Eli Lilly Deserve a Spot in Your Portfolio?more

Two red flags do appear regarding its growth (somewhat weak) and its financing (by far the most leveraged).

UPDATE 1-Doctors back Pfizer arthritis pill despite deathsmore

for anti-TNF injections (Updates with more reaction from doctor, analyst) By Ben Hirschler LONDON, May 25 (Reuters) -...

Analyst Argues A Pfizer Break-Up Wouldn't Workmore

Pfizer shares are up 17% this year on hopes that the drug giant will break itself into as many as five parts, which,...

Deaths in Pfizer arthritis trial under microscopemore

ballpark" as anti-TNF injections By Ben Hirschler LONDON, May 25 (Reuters) - Four deaths during a study of...

Top Sources: Pfizer

  • blogs.barrons.com
  • BusinessWeek
  • knowledge.wharton.upenn.edu
  • online.wsj.com
  • MarketWatch
  • SeekingAlpha.com
  • TheStreet.com
  • Forbes.com
  • startribune.com
  • clinicaspace.com

Most Active Users in this Topic

see all contributors in Pfizer

Featured White Papers

Post a Job

Jobs in this Topic

NCBiotech Industrial Fellowship - Icagen, Inc. (Pfizer) North Carolina Biotechnology Center | Durham, NC
Posted: Apr 10
GM - Pfizer Nutrition Global Analytics Mindlance | Madison, NJ
Posted: May 26
Global Marketing Research Analyst - Pfizer Animal Health Pfizer | Madison, NJ
Posted: May 24
Pfizer-Summer Student Worker Program Kalamazoo, MI
Posted: May 20

Report comment contains invalid characters. ()
cancel
Search Cancel